D

Dong-A ST

KRX-170900
Korea Stock Exchange
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#17519
Country Rank
#494
Market Cap
$314.5 M
Price
$34.32
Change (%)
0.11%
Volume
13,085

Dong-A ST's latest marketcap:

$314.5 M

As of 07/30/2025, Dong-A ST's market capitalization has reached $314.5 M. According to our data, Dong-A ST is the 17519th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap $314.5 M
Revenue (ttm) $524.12 M
Net Income (ttm) $-565,055.61
Shares Out 9.16 M
EPS (ttm) $-0.06
Forward PE 21.05
Ex-Dividend Date 03/13/2025
Earnings Date 07/28/2025
Market Cap Chart
Data Updated: 07/30/2025

Dong-A ST's yearly market capitalization.

Dong-A ST has seen its market value drop from ₩705.89 B to ₩434.79 B since 2014, representing a total decrease of 38.41% and an annual compound decline rate (CAGR) of 4.48%.
Date Market Cap(₩) Market Cap(USD) Change (%) Global Rank
07/30/2025 ₩434.79 B $314.5 M -17.77% 17519
12/30/2024 ₩528.23 B $353.91 M -11.66% 15297
12/28/2023 ₩597.95 B $460.42 M 14.22% 13582
12/29/2022 ₩523.48 B $413.55 M -13.38% 13484
12/30/2021 ₩604.34 B $507.65 M -19.17% 13259
12/30/2020 ₩747.64 B $687.83 M -25.55% 9873
12/30/2019 ₩1 T $863.58 M 13.88% 7473
12/28/2018 ₩881.81 B $784.81 M 4.92% 7034
12/28/2017 ₩840.46 B $781.63 M -5.6% 8264
12/29/2016 ₩890.36 B $730.09 M -24.63% 7893

Company Profile

About Dong-A ST Co., Ltd.

Dong-A ST Co., Ltd. is a pharmaceutical company specializing in the development, manufacturing, and marketing of ethical drugs and medical devices. Founded in 1932 and headquartered in Seoul, South Korea, the company operates both domestically and internationally.

Key Pharmaceutical Products

  • Closerin Cap – For active pulmonary and extra-pulmonary tuberculosis.
  • Dulastin PFS & Leucostim Injection/PFS – Treats neutropenia in chemotherapy patients.
  • Eporon Inj./PFS – Addresses anemia linked to chronic renal failure.
  • Gemcit Inj. – Targets non-small cell lung, pancreatic, breast, bladder, and ovarian cancers.
  • Gonadopin Inj./PFS – Used for infertility and anovulation treatment.
  • Growtropin II Inj./AQ Cartridge – Treats growth failure due to inadequate growth hormone secretion.
  • Mainta Inj. – For non-small cell lung cancer and malignant pleural mesothelioma.
  • Monotaxel Inj. – Treats breast, lung, prostate, head/neck cancers, and gastric adenocarcinoma.
  • Motilitone Tab. – Used in functional dyspepsia treatment.
  • Stillen Tab. – Addresses gastritis.
  • Suganon Tab. & Sugamet XR Tab. – For type 2 diabetes mellitus.
  • Terizidone Tab. – Treats active pulmonary and extra-pulmonary tuberculosis.
  • Zydena Tab. – For erectile dysfunction treatment.

Additional Offerings

  • Licensed-in and licensed-out pharmaceutical products.
  • Medical devices, including high-tech solutions, custom-made products, and artificial cardiac circuits for open-heart surgery.

Frequently Asked Questions

  • What is Dong-A ST's (KRX-170900) current market cap?
    As of 07/30/2025, Dong-A ST (including the parent company, if applicable) has an estimated market capitalization of $314.5 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Dong-A ST global market capitalization ranking is approximately 17519 as of 07/30/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.